Mitonafide

CAS No. 54824-17-8

Mitonafide ( NSC300288; NSC-300288; NSC 300288; Mitonafide )

Catalog No. M27823 CAS No. 54824-17-8

Mitonafide suppresses the activity of M. tuberculosis NAD+ dependent DNA ligase A. Mitonafide is a DNA intercalating agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 36 Get Quote
5MG 58 Get Quote
10MG 87 Get Quote
25MG 178 Get Quote
50MG 295 Get Quote
100MG 483 Get Quote
200MG 690 Get Quote
500MG 1035 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Mitonafide
  • Note
    Research use only, not for human use.
  • Brief Description
    Mitonafide suppresses the activity of M. tuberculosis NAD+ dependent DNA ligase A. Mitonafide is a DNA intercalating agent.
  • Description
    Mitonafide suppresses the activity of M. tuberculosis NAD+ dependent DNA ligase A. Mitonafide is a DNA intercalating agent.
  • Synonyms
    NSC300288; NSC-300288; NSC 300288; Mitonafide
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    ATP citrate lyase;GPR40;GPR120
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    54824-17-8
  • Formula Weight
    313.3
  • Molecular Formula
    C16H15N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C)CCN1C(=O)c2cccc3cc(cc(C1=O)c23)[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hara T, Hirasawa A, Sun Q, et al. Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn Schmiedebergs Arch Pharmacol. 2009;380(3):247-255.
molnova catalog
related products
  • Mecillinam

    Mecillinam, an extended-spectrum penicillin antibiotic, is considered to be active against Gram-negative bacteria by binding specifically to penicillin-binding protein 2 (PBP2).

  • Entospletinib

    Entospletinib (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable.

  • BM212

    A novel antitubercular agent that possesses strong inhibitory activity against both Mycobacterium tuberculosis (MIC=0.7-1.5 ug/ml) and some nontuberculosis mycobacteria, inhibits transport activity of MmpL3.